This improvement in workflow and robustness provides valuable end-user benefits. Veriflow’s proprietary enzymes and inhibitor sequestration technologies eliminate the need for sample purification or DNA extraction, thereby significantly reducing the complexity of sample prep. Veriflow uses a unique, proprietary approach to DNA amplification that overcomesinterference from inhibitors, even in the most challenging matrices. The process starts with target DNA amplification, where proprietary enzymes multiple the DNA target sequence to detectable levels. Veripro – our latest innovative platform - incorporates key elements of our core technology, Veriflow, and is compatible with RT-PCR systems to enable multiplexed assays, high throughput analyses, and risk-based assessment. Veriflow utilizes DNA Signature Capturing Technology, which provides unmatched specificity and unrivaled sensitivity with zero compromises on ease of use in the production environment. It was also designed with a comprehensive set of features to meet the diverse needs of end-users in a variety of industries. Our core technology, Veriflow, was engineered to improve the user experience while dramatically reducing the capital and operational costs associated with existing PCR technologies. Existing rapid methods were both complex and expensive or had limitations regarding sensitivity and accuracy. Although many PCR-based testing methods have been around for decades, most are dated and have inherent issues. The inception of our technology began with a goal of revolutionizing molecular diagnostics. Game-changing molecular solutions platformsįor over a decade, Invisible Sentinel has been committed to providing game-changing technologies for microbial detection for the food and beverage industries.
0 kommentar(er)
